Related Experiment Video
Updated: Jun 21, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Mastocytosis.
Luciana Cirillo Maluf1, Jefferson Alfredo de Barros, Carlos D Aparecida Dos Santos Machado Filho
1Mestre em Ciências da Saúde pela Faculdade de Medicina do ABC, Preceptor da disciplina de Dermatologia da Faculdade de Medicina do ABC, Santo André (SP), Brazil. lcmaluf@hotmail.com
Anais Brasileiros De Dermatologia
|August 12, 2009
Summary
Mastocytosis involves abnormal mast cell buildup. This review clarifies diagnosis, classification, and treatment standards for mast cell disorders, aiding medical education.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Mastocytosis is a rare disorder defined by the pathological accumulation and activation of mast cells in various tissues and organs.
- Current classification and diagnostic criteria for mastocytosis are established, yet standardization in diagnostic testing, clinical evaluation, and treatment response assessment is needed.
Purpose of the Study:
- To conduct an extensive literature review on mastocytosis.
- To provide comprehensive knowledge on the etiopathological and pathophysiological mechanisms of mastocytosis.
- To emphasize diagnosis, classification, and treatment of mastocytosis for continued medical education.
Main Methods:
- Extensive literature review.
- Synthesis of existing knowledge on mastocytosis mechanisms, diagnosis, classification, and treatment.
Main Results:
- Comprehensive overview of mastocytosis etiopathology and pathophysiology.
- Detailed examination of current diagnostic and classification standards.
- Discussion on treatment strategies and response evaluation.
Conclusions:
- Highlights the need for standardized approaches in managing mastocytosis.
- Provides a consolidated resource for understanding and managing mastocytosis.
- Aims to enhance medical education and clinical practice related to mastocytosis.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...